NorthStar Asset Management (New Jersey)’s AbbVie ABBV Stock Holding History

NorthStar Asset Management (New Jersey)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$712K	Sell	3,273 -686	-17%	-$152K	0.34%	48
2025 Q4	$905K	Buy	3,959 +9	+0.2%	+$2.05K	0.41%	44
2025 Q3	$915K	Buy	3,950 +10	+0.3%	+$2.04K	0.44%	41
2025 Q2	$731K	Buy	3,940 +67	+2%	+$12.5K	0.39%	46
2025 Q1	$811K	Sell	3,873 -146	-4%	-$28.4K	0.51%	36
2024 Q4	$714K	Sell	4,019 -286	-7%	-$52.6K	0.45%	40
2024 Q3	$850K	Sell	4,305 -91	-2%	-$17K	0.57%	34
2024 Q2	$754K	Sell	4,396 -101	-2%	-$16.7K	0.52%	37
2024 Q1	$819K	Buy	4,497 +90	+2%	+$15.5K	0.62%	34
2023 Q4	$683K	Buy	+4,407	New	+$642K	0.62%	36

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NorthStar Asset Management (New Jersey)'s ABBV Position: Q1 2026 in Review

NorthStar Asset Management (New Jersey) reduced its AbbVie (ABBV) stake by 17% in Q1 2026, selling an estimated $152K and leaving 3,273 shares worth $712K. The position accounts for 0.34% of the portfolio, ranked #48.

NorthStar Asset Management (New Jersey) first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $915K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

NorthStar Asset Management (New Jersey) held 3,273 shares of AbbVie worth $712K as of Q1 2026.
NorthStar Asset Management (New Jersey) sold 686 AbbVie shares in Q1 2026, an estimated $152K.
AbbVie made up 0.34% of NorthStar Asset Management (New Jersey)'s portfolio in Q1 2026, its #48 holding.
NorthStar Asset Management (New Jersey) first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
NorthStar Asset Management (New Jersey)'s AbbVie position peaked at $915K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on NorthStar Asset Management (New Jersey)'s 13F filing for Q1 2026, filed 8 May 2026.